Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction

Anthony P Carnicelli1, Ruth Owen2, Stuart J Pocock3

  • 1Duke University Hospital, Durham, North Carolina, USA.

Open Heart
|December 16, 2021
PubMed

Insights

Patients with atrial fibrillation (AF) after myocardial infarction (MI) experience poorer quality of life and increased hospitalization risk. Many with AF post-MI remain undertreated with oral anticoagulants, despite high stroke risk.

Area of Science:

  • Cardiology
  • Clinical Research
  • Public Health

Background:

  • Atrial fibrillation (AF) and myocardial infarction (MI) frequently coexist and are linked to adverse health outcomes.
  • The impact of AF on the quality of life and prognosis for patients following MI is not well understood.

Purpose of the Study:

  • To compare the characteristics, quality of life, and clinical outcomes of stable patients post-MI with and without AF.
  • To identify potential gaps in the management of oral anticoagulation in patients with AF post-MI.

Main Methods:

  • Analysis of data from the prospective, international, observational TIGRIS registry, including 8406 patients 1-3 years post-MI.
  • Assessment of quality of life using EQ-5D at baseline and clinical outcomes over 2 years of follow-up.
  • Multivariable adjustment to compare outcomes between patients with and without AF.

Main Results:

  • AF was present in 8.5% of patients; these patients were older with more comorbidities.
  • Patients with AF reported significantly lower quality of life scores (EQ-5D index, VAS, usual activities, pain/discomfort).
  • Despite high CHA2DS2-VASc scores, less than half of AF patients were on oral anticoagulants; they experienced higher all-cause hospitalization rates (aRR 1.25) but similar mortality.

Conclusions:

  • Stable patients post-MI with AF exhibit poorer quality of life and an elevated risk of clinical events compared to those without AF.
  • A significant proportion of patients with AF post-MI are undertreated with oral anticoagulants, indicating a need for improved management strategies.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
63
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
76
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
82
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
38
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
108